Iron 20/B12-TPV belongs to the group of anti-anaemic agents, stimulants of hematopoiesis, as well as to the group of veterinary products for the metabolic care improvement.
The veterinary product is used for prevention and treatment of iron deficiency anaemia caused by iron and cyanocobalamin deficiency in piglets and calves.
Iron is part of a number of tissue enzymes (cytochromes, cytochrome oxidases, peroxidases, etc.). These enzymes are catalysts of cellular respiration, stimulate oxidative reactions, increase the metabolic and phagocytic activity of leukocytes, increase the efficiency of intracellular digestion and barrier properties of the skin, and contribute the general resistance of the organism.
From the injection site, iron gradually enters the blood stream and binds to a specific blood plasma protein - transferrin. Each transferrin molecule binds two trivalent iron. The iron-transferrin complex is deposited in the liver, spleen, bone marrow and is gradually consumed for the synthesis of haemoglobin, myoglobin.
Cyanocobalamin is converted in the body to adenosylcobalamin (cobamamide), which is the active form of vitamin B12. Cyanocobalamin has high biological activity, is a growth factor, is necessary for normal haematopoiesis and maturation of erythrocytes, participates in the synthesis of methyl groups and in the formation of choline, methionine, creatine, nucleic acids. It accumulates in the liver, is excreted from the body mainly by kidneys.
The apparent elimination half-life of iron from blood plasma is five hours. A small amount of iron is excreted in the urine. Dextran is metabolized and excreted by kidneys.
The veterinary product, according to the exposure degree refers to low-hazard substances (hazard class 4 according to GOST 12.1.007-76).
